CompoAtlas

EPO Blast Fruit Punch

Retirée du marché américain le 28 September 2023 (selon le DSLD)

Xero Limits, food supplement from the US market

Label withdrawn from the US market. EPO Blast Fruit Punch (Xero Limits), a food supplement au code-barres 891597002184, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. Doses of folates are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
Xero Limits
Barcode
891597002184
Form
Powder
One serving
1 packet
Servings
up to 1 serving per day
Other ingredients (in English, as written)
Citric Acid, Natural and Artificial flavor, Acesulfame Potassium, Sucralose, Silica, Red 40
Ingredient (as written, in English)CategoryPer serving
CaloriesOther0 kcal
Total CarbohydratesCarbohydrate0 g
SugarCarbohydrate0 g
Vitamin B6Vitamin10 mg
FolateVitamin400 µg
Vitamin B12Vitamin20 µg
IronMineral2 mg
MagnesiumMineral3 mg
SodiumMineral50 mg
PotassiumMineral382 mg
EPO Blast (Combination)Blend10.688 Gram(s)
Muscle Fiber Volumizing Matrix:Blendnot stated
Creatine Ethyl EsterOther substancenot stated
Dicreatine MalateOther substancenot stated
Creatine MonohydrateOther substancenot stated
Creatine GluconateOther substancenot stated
Glycerol MonostearateOthernot stated
Guanipro Guanidino Propionic AcidOther substancenot stated
Multi-Pump Nitric Oxide Stimulating Blend:Blendnot stated
L-ArginineAmino acidnot stated
Arginine Ethyl EsterOther substancenot stated
AAKGOther substancenot stated
Cnidium monnier (Cnidium monnieri)Plantnot stated
PycnogenolPlantnot stated
NADOther substancenot stated
CitrullineAmino acidnot stated
MalateOther substancenot stated
EPO Blood Building TechnologyBlendnot stated
Arachidonic AcidFatty acidnot stated
NattokinaseEnzymenot stated
Echinacea pupurea extract (Echinacea purpurea)Plantnot stated
Portulaca oleracea extract (Portulaca oleracea)Plantnot stated
CobaltMineralnot stated
Muscle Endurance Beta Alanine pH Buffering System:Blendnot stated
Beta-AlanineAmino acidnot stated
Beta-Alanine Ethyl EsterAmino acidnot stated
SodiumMineralnot stated
PotassiumMineralnot stated
HistidineAmino acidnot stated
MagnesiumMineralnot stated
LeucineAmino acidnot stated
IsoleucineAmino acidnot stated
ValineAmino acidnot stated
Psychotropic EnergizersBlendnot stated
TaurineOther substancenot stated
GlucuronolactoneOther substancenot stated
Caffeine AnhydrousOther substancenot stated
Beta PEAOther substancenot stated
5-HTPAmino acidnot stated
Acetyl TyrosineOther substancenot stated
VinpocetineOther substancenot stated
Yohimbine HClOther substancenot stated
GinkgoPlantnot stated

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Echinacea pupurea extract
    Read the warning, when it applies and the studies cited

    ECHINACEA - ECHINACEA PURPUREA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (EMA 2015; Gardner and McGuffin 2013; Brinker 2010).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: Preparations containing herb top.

    Stop use if hypersensitivity/allergy occurs (MHRA 2018; EMA 2015; Kligler 2003; WHO 1999).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • 5-HTP
    Read the warning, when it applies and the studies cited

    5-HTP

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking carbidopa or health products with serotonergic activity such as mood balance supplements, cough medication containing dextromethorphan, pain killers or medications for nausea or migraine (Mayo Clinic Staff 2022; Patel and Marzella 2017; Turner et al 2006).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product exercise caution while driving or using machinery, as you may experience drowsiness (Berardi et al. 2002).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All uses (excluding weight management).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Weight management.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Condition of application: Healthy mood balance; Fibromyalgia symptoms.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a psychological disorder such as anxiety or depression.

    Contraindications

    Condition of application: All uses.

    Do not use if you have scleroderma (Lampert et al. 1992; Sternberg et al. 1980).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking antidepressants (Mayo Clinic Staff 2022; Patel and Marzella 2017).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Weight management.

    Do not use if you are pregnant (HC 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Turner et al. 2006; Byerley et al. 1987).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience skin hardening, pain or stiffness of muscles or joints, tremors, agitation/confusion, or an increased heart rate (Boyer 2023; Varga 2023; Mayo Clinic Staff 2022; Patel and Marzella 2017; Das et al. 2004; Erner et al. 2003; Lampert et al. 1992; Sternberg et al. 1980).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 August 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : Xero Limits

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2012. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line